8:06 am Peregrine Pharma: Data Presented at AACR support potential of combining Peregrine’s PS-targeting immunotherapy agent Bavituximab with irradiation in Lung Cancer

more

View todays social media effects on PPHM

View the latest stocks trending across Twitter. Click to view dashboard

See who Peregrine is hiring next, click here to view